Abstract
Chitinases (EC.3.2.1.14) hydrolyze the β-1,4-linkages in chitin, an abundant N-acetylglucosamine (GlcNAc) polysaccharide that is a structural component of protective biological matrices of invertebrate such as insect exoskeletons and fungal cell walls. Chitinases cleave chitin and contain the conserved sequence motif DXXDXDXE, in which the glutamate is the catalytic residue. Chitinases are found in species including archaea, bacteria, fungi, plants, and animals. On the basis of sequence homologies, chitinases fall into two groups: families 18 and 19 of glycosyl hydrolases. Members of family 18 employ a substrate-assisted reaction mechanism (van Aalten et al. 2001), whereas those of family 19 adopt a fold-and-reaction mechanism similar to that of lysozyme (Monzingo et al. 1996), suggesting that these families evolved independently to deal with chitin. The glycoside hydrolase 18 (GH18) family of chitinases is an ancient gene family widely expressed in archea, prokaryotes and eukaryotes. Since chitin is an important structural component of pathogens like fungi as well as a constituent of the mammalian diet, a dual function for mammalian chitinases in innate immunity and food digestion has been envisioned (Suzuki et al. 2002; Boot et al. 2005a). Indeed, for human chitotriosidase, an enzyme predominantly expressed by phagocytes, a fungistatic effect has been demonstrated (van Eijk et al. 2005). Several studies have tried to link a common chitotriosidase deficiency to susceptibility for infection by chitin-containing parasites (Bussink et al. 2006). The physiological function of the second mammalian chitinase, acidic mammalian chitinase (AMCase), has attracted considerable attention due to a report linking the protein to the pathophysiology of asthma (Zhu et al. 2004).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berntsen A, Trepiakas R, Wenandy L et al (2008) Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial. J Immunother 31:771–780
Bhat KP, Pelloski CE, Zhang Y, et al (2008) Selective repression of YKL-40 by NF-kB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett 582:3193–3200
Bigg HF, Wait R, Rowan AD, Cawston TE (2006) The mammalian chitinase-like lectin, YKL-40, binds specifically to type 1 collagen and modulates the rate of type 1 collagen fibril formation. J Biol Chem 281:21082–21095
Biggar RJ, Johansen JS, Smedby KE et al (2008) Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma. Clin Cancer Res 14:6974–6978
Bilim O, Takeishi Y et al (2010) Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure. J Card Fail 16:873–879
Bonneh-Barkay D, Wang G, Starkey A et al (2010) In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation 7:34
Boot RG, van Achterberg TA, van Aken BE et al (1999) Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19:687–694
Boot RG, Blommaart EF, Swart E (2001) Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem 276:6770–6778
Boot RG, Bussink AP, Aerts JM (2005a) Human acidic mammalian chitinase erroneously known as eosinophil chemotactic cytokine is not the ortholog of mouse YM1. J Immunol 175:2041–2042
Boot RG, Bussink AP, Verhoek M et al (2005b) Marked differences in tissue-specific expression of chitinases in mouse and man. J Histochem Cytochem 53:1283–1292
Brasso K, Christensen IJ, Johansen JS et al (2006) Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma. Prostate 66:503–513
Bromberg J, Wang TC (2009) Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15:79–80
Brunner JK, Scholl-Bürgi S, Hössinger D et al (2008) Chitotriosidase activity in juvenile idiopathic arthritis. Rheumatol Int 28:949–950
Buhi WC (2002) Characterization and biological roles of oviduct-specific, oestrogen-dependent glycoprotein. Reproduction 123:355–362
Bussink AP, van Eijk M, Renkema GH et al (2006) The biology of the Gaucher cell: the cradle of human chitinases. Int Rev Cytol 252:71–128
Bussink AP, Speijer D, Aerts JM et al (2007) Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics 177:959–970
Catalán V, Gómez-Ambrosi J, Rodríguez A et al (2011) Icreased circulating and visceral adipose tissue expression levels of ykl-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass. J Clin Endocrinol Metab 96:200–209
Chang NC, Hung SI, Hwa KY et al (2001) A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem 276:17497–17506
Chen C-C, Llado V, Eurich K, et al (2011) Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clin Immunol 140:268–275
Chupp GL, Lee CG, Jarjour N et al (2007) A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 357:2016–2027
Cintin C, Johansen JS, Christensen IJ et al (2002) High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95:267–274
Collins PD, Mpofu C, Watson AJ, Rhodes JM (2006) Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 336:CD000279
Coskun U, Yamac D, Gulbahar O et al (2007) Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response? Neoplasma 54:348–352
Craig-Schapiro R, Perrin RJ, Roe CM et al (2010) YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry 68:903–912
De Ceuninck F, Pastoureau P, Bouet F et al (1998) Purification of guinea pig YKL40 and modulation of its secretion by cultured articular chondrocytes. J Cell Biochem 69:414–424
De Ceuninck F, Gaufillier S, Bonnaud A et al (2001) YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 285:926–931
DeSouza MM, Murray MK (1995) An estrogen-dependent sheep oviductal glycoprotein has glycan linkages typical of sialomucins and does not contain chitinase activity. Biol Reprod 53:1517–1526
Diefenbach CS, Shah Z, Iasonos A et al (2007) Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer. Gynecol Oncol 104:435–442
Eurich K, Segawa M, Toei-Shimizu S et al (2009) Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells. World J Gastroenterol 15:5249–5259
Fitches E, Wilkinson H, Bell H et al (2004) Cloning, expression and functional characterisation of chitinase from larvae of tomato moth (Lacanobia oleracea): a demonstration of the insecticidal activity of insect chitinase. Insect Biochem Mol Biol 34:1037–1050
Fontana RJ, Dienstag JL, Bonkovsky HL et al (2010) Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut 59:1401–1409
Funkhouser JD, Aronson NN Jr (2007) Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol Biol 7:96
Fusetti F, Pijning T, Kalk KH et al (2003) Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39. J Biol Chem 278:37753–37760
Gaidamashvili M, Ohizumi Y, Iijima S et al (2004) Characterization of the yam tuber storage proteins from Dioscorea batatas exhibiting unique lectin activities. J Biol Chem 279:26028–26035
Grivennikov S, Karin E, Terzic J et al (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15:103–113
Gronlund B, Høgdall EV, Christensen IJ et al (2006) Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA 125). Int J Biol Markers 21:141–148
Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803–25810
Harbord M, Novelli M, Canas B et al (2002) Ym1 is a neutrophil granule protein that crystallizes in p47phox-deficient mice. J Biol Chem 277:5468–5475
Hartl D, Lee CG, Da Silva CA et al (2009) Novel biomarkers in asthma: chemokines and chitinase-like proteins. Curr Opin Allergy Clin Immunol 9:60–66
Hattori N, Oda S, Sadahiro T et al (2009) YKL-40 identified by proteomic analysis as a biomarker of sepsis. Shock 32:393–400
Henrissat B, Davies G (1997) Structural and sequence-based classification of glycoside hydrolases. Curr Opin Struct Biol 7:637–644
Hoell IA, Dalhus B, Heggset EB et al (2006) Crystal structure and enzymatic properties of a bacterial family 19 chitinase reveal differences from plant enzymes. FEBS J 273:4889–4900
Høgdall EV, Ringsholt M, Høgdall CK et al (2009) YKL-40 tissue expression and plasma levels in patients with ovarian cancer. BMC Cancer 9:8
HogenEsch H, Dunham A, Seymour R et al (2006) Expression of chitinase-like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice. Exp Dermatol 15:808–814
Homer RJ, Zhu Z, Cohn L et al (2006) Differential expression of chitinases identify subsets of murine airway epithelial cells in allergic inflammation. Am J Physiol Lung Cell Mol Physiol 291:502–511
Hormigo A, Gu B, Karimi S et al (2006) YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clin Cancer Res 12:5698–5704
Houston DR, Recklies AD, Krupa JC et al (2003) Structure and ligandinduced conformational change of the 39-kDa glycoprotein from human articular chondrocytes. J Biol Chem 278:30206–30212
Huang K, Wu LD (2009) YKL-40: a potential biomarker for osteoarthritis. J Int Med Res 37:18–24
Huang Y, Prasad M, Lemon WJ et al (2001) Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98:15044–15049
Jensen BV, Johansen JS, Price PA (2003) High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res 9:4423–4434
Johansen JS (2006) Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53:172–209
Johansen JS, Williamson MK, Rice JS et al (1992) Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 7:501–512
Johansen JS, Cintin C, Jørgensen M et al (1995) Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 31A:1437–1442
Johansen JS, Møller S, Price PA et al (1997) Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? Scand J Gastroenterol 32:582–590
Johansen JS, Baslund B, Garbarsch C et al (1999a) YKL-40 in giant cells and macrophages from patients with giant cell arthritis. Arthritis Rheum 42:2624–2630
Johansen JS, Stoltenberg M, Hansen M et al (1999b) Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology (Oxford) 38:618–626
Johansen JS, Drivsholm L, Price PA, Christensen IJ (2004) High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 46:333–340
Johansen JS, Jensen BV, Roslind A et al (2006) Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev 15:194–202
Johansen JS, Brasso K, Iversen P et al (2007) Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival. Clin Cancer Res 13:3244–3249
Johansen JS, Pedersen AN, Schroll M et al (2008) High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin Exp Immunol 151:260–266
Johansen JS, Bojesen SE, Mylin AK et al (2009) Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. J Clin Oncol 27:572–578
Johansen JS, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG et al (2010) Plasma YKL-40 and total and disease-specific mortality in the general population. Clin Chem 56:1580–1591
Junker N, Johansen JS, Andersen CB, Kristjansen PE (2005a) Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer 48:223–231
Junker N, Johansen JS, Hansen LT et al (2005b) Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Sci 96:183–190
Kastrup J, Johansen JS, Winkel P et al (2009) High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J 30:1066–1072
Kawada M, Hachiya Y, Arihiro A, Mizoguchi E (2007) Role of mammalian chitinases in inflammatory conditions. Keio J Med 56:21–27
Kawada M, Chen CC, Arihiro A et al (2008) Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein. Lab Invest 88:883–895
Kawamura K, Shibata T, Saget O et al (1999) A new family of growth factors produced by the fat body and active on Drosophila imaginal disc cells. Development 126:211–219
Kazakova MH, Sarafian VS (2009) YKL-40–a novel biomarker in clinical practice? Folia Med (Plovdiv) 51:5–14
Kjaergaard AD, Bojesen SE, Johansen JS, Nordestgaard BG (2010) Elevated plasma YKL-40 levels and ischemic stroke in the general population. Ann Neurol 68:672–680
Korthagen NM, van Moorsel CH, Barlo NP et al (2011) Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respir Med 105:106–113
Krause SW, Rehli M, Kreutz M et al (1996) Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 60:540–545
Kronborg G, Østergaard C, Weis N et al (2002) Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated to the outcome of the disease. Scand J Infect Dis 34:323–326
Kucur M, Isman FK, Balci C et al (2008) Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol 26:47–52
Kzhyshkowska J, Mamidi S, Gratchev A et al (2006) Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107:3221–3228
Lee E, Jin M, Quan Z et al (2008) Effect of dexamethasone on STAT6-dependent Ym1/2 expression in vivo and in vitro. Biol Pharm Bull 31:1663–1666
Lee CG, Hartl D, Lee GR et al (2009) Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med 206:1149–1166
Lee CG, Da Silva C, Dela Cruz CS et al (2011) Role of Chitin, Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury. Annu Rev Physiol 73:479–501
Li H, Greene LH (2010) Sequence and structural analysis of the chitinase insertion domain reveals two conserved motifs involved in chitin-binding. PLoS One 5:e8654
Ling H, Recklies AD (2004) The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-α. Biochem J 380:651–659
Malinda KM, Ponce L, Kleinman HK et al (1999) Gp38 k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 250:168–173
Mathiasen AB, Henningsen KM, Harutyunyan MJ et al (2010) YKL-40: a new biomarker in cardiovascular disease? Biomark Med 4:591–600
Matsuura H, Hartl D, Kang MJ et al (2011) Role of Breast Regression Protein (BRP)-39 in the Pathogenesis of Cigarette Smoke-Induced Inflammation and Emphysema. Am J Respir Cell Mol Biol 44:777–786
Mitsuhashi A, Matsui H, Usui H et al (2009) Serum YKL-40 as a marker for cervical adenocarcinoma. Ann Oncol 20:71–77
Mizoguchi E (2006) Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology 130:398–411
Mizoguchi E, Mizoguchi A (2007) Is the sugar always sweet in intestinal inflammation? Immunol Res 37:47–60
Mohanty AK, Singh G, Paramasivam M et al (2003) Crystal structure of a novel regulatory 40 kDa mammary gland protein (MGP-40) secreted during involution. J Biol Chem 278:14451–14460
Monzingo AF, Marcotte EM, Hart PJ et al (1996) Chitinases, chitosanases, and lysozymes can be divided into procaryotic and eucaryotic families sharing a conserved core. Nat Struct Biol 3:133–140
Morrison BW, Leder P (1994) Neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 9:3417–3426
Mygind ND, Harutyunyan MJ, Mathiasen AB et al (2011) The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. Inflamm Res 60:281–287
Mylin AK, Rasmussen T, Johansen JS et al (2006) Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells. Eur J Haematol 77:416–424
Mylin AK, Andersen NF, Johansen JS et al (2009) Serum YKL-40 and bone marrow angiogenesis in multiple myeloma. Int J Cancer 124:1492–1494
Nielsen AR, Erikstrup C, Johansen JS et al (2008) Plasma YKL-40: a BMI-independent marker of type 2 diabetes. Diabetes 57:3078–3082
Nigro JM, Misra A, Zhang L et al (2005) Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 65:1678–1686
Nishikawa KC, Millis AJT (2003) Gp38 k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res 287:79–87
Nøjgaard C, Høst NB, Christensen IJ et al (2008) Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 19:257–263
Nutt CL, Betensky RA, Brower MA et al (2005) YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas. Clin Cancer Res 11:2258–2264
Ober C, Chupp GL (2009) The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases. Curr Opin Allergy Clin Immunol 9:401–408
Ober C, Tan Z, Sun Y, Possick JD et al (2008) Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 358:1682–1691
Pearson G, Robinson F, Beers Gibson T et al (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153–183
Peng C, Peng J, Jiang L et al (2010) YKL-40 protein levels and clinical outcome of human endometrial cancer. J Int Med Res 38:1448–1457
Punzi L, Oliviero F, Plebani M (2005) New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment. Crit Rev Clin Lab Sci 42:279–309
Qin W, Zhu W, Schlatter L et al (2007) Increased expression of the inflammatory protein YKL-40 in precancers of the breast. Int J Cancer 121:1536–1542
Rathcke CN, Vestergaard H (2009) YKL-40–an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 8:61
Rathcke CN, Johansen JS, Vestergaard H (2006) YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 55:53–59
Rathcke CN, Persson F, Tarnow L et al (2009) YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 32:323–328
Recklies AD, White C, Ling H (2002) The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J 365:119–126
Rehli M, Krause SW, Andreesen R (1997) Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43:221–225
Rehli M, Niller HH, Ammon C et al (2003) Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem 278:44058–44067
Renkema GH, Boot RG, Au FL et al (1998) Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 251:504–509
Roslind A, Johansen JS, Junker N et al (2007) YKL-40 expression in benign and malignant lesions of the breast: a methodologic study. Appl Immunohistochem Mol Morphol 15:371–381
Roslind A, Johansen JS, Christensen IJ et al (2008) High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival. Int J Cancer 122:857–863
Saidi A, Javerzat S, Bellahcene A et al (2008) Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int J Cancer 122:2187–2198
Schmidt H, Johansen JS, Gehl J et al (2006) Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer 106:1130–1139
Shuhui L, Mok YK, Wong WS (2009) Role of mammalian chitinases in asthma. Int Arch Allergy Immunol 149:369–377
Sjögren H, Meis-Kindblom JM, Orndal C et al (2003) Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses. Am J Pathol 162:781–792
Sohn MH, Lee JH, Kim KW et al (2009) Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med 179:449–456
Sun YJ, Chang NC, Hung SI et al (2001) The crystal structure of a novel mammalian lectin, Ym1, suggests a saccharide binding site. J Biol Chem 276:17507–17514
Suzuki K, Taiyoji M, Sugawara N et al (1999) The third chitinase gene (chiC) of Serratia marcescens 2170 and the relationship of its product to other bacterial chitinases. Biochem J 343:587–596
Suzuki M, Fujimoto W, Goto M et al (2002) Cellular expression of gut chitinase mRNA in the gastrointestinal tract of mice and chickens. J Histochem Cytochem 50:1081–1089
Svane IM, Pedersen AE et al (2007) Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers. Cancer Immunol Immunother 56:1485–1499
Tanwar MK, Gilbert MR, Holland EC (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62:4364–4368
Terwisscha van Scheltinga AC, Hennig M, Dijkstra BW (1996) The 1.8 Å resolution structure of hevamine, a plant chitinase/lysozyme, and analysis of the conserved sequence and structure motifs of glycosyl hydrolase family 18. J Mol Biol 262:243–257
Tsai ML, Liaw SH, Chang NC (2004) The crystal structure of Ym1 at 1.31 A resolution. J Struct Biol 148:290–296
Tsuruha J, Masuko-Hongo K, Kato T et al (2002) Autoimmunity against YKL-39, a human cartilage derived protein, in patients with osteoarthritis. J Rheumatol 29:1459–1466
Ujita M, Sakai K, Hamazaki K et al (2003) Carbohydrate binding specificity of the recombinant chitin-binding domain of human macrophage chitinase. Biosci Biotechnol Biochem 67: 2402–2407
Vaaje-Kolstad G, Vasella A, Peter MG, Netter C, Houston DR et al (2004) Interactions of a family 18 chitinase with the designed inhibitor Hm508 and its degradation product, chitobiono-δ-lactone. J Biol Chem 279:3612–3619
van Aalten DM, Komander D, Synstad B et al (2001) Structural insights into the catalytic mechanism of a family 18 exochitinase. Proc Natl Acad Sci USA 98:8979–8984
van Dekken H, Wink JC, Vissers KJ et al (2007) Wnt pathway-related gene expression during malignant progression in ulcerative colitis. Acta Histochem 109:266–272
van Eijk M, van Roomen CP, Renkema GH et al (2005) Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 17:1505–1512
Varela PF, LIera AS, Mariuzza RA, Tormo J (2002) Crystal structure of imaginal disc growth factor-2. A member of a new family of growth-promoting glycoproteins from Drosophila melanogaster. J Biol Chem 277:13229–13236
Vind I, Johansen JS, Price PA, Munkholm P (2003) Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 38:599–605
Volck B, Price PA, Johansen JS et al (1998) YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 110:351–360
Wang Y, Ripa SR, Johansen JS et al (2008) YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J 42:295–302
Ward JM, Yoon M, Anver MR et al (2001) Hyalinosis and Ym1/Ym2 gene expression in the stomach and respiratory tract of 129 S4/SvJae and wild-type and CYP1A2-null B6, 129 mice. Am J Pathol 158:323–332
Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427–434
Yamac D, Ozturk B, Coskun U (2008) Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv Ther 25:801–809
Zhang W, Murao K, Zhang X (2010) Resveratrol represses YKL-40 expression in human glioma U87 cells. BMC Cancer 10:593
Zhao X, Tang R, Gao B et al (2007) Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 80:12–18
Zhu Q, Deng Y, Vanka P et al (2004a) Computational identification of novel chitinase-like proteins in the Drosophila melanogaster genome. Bioinformatics 20:161–169
Zhu Z, Zheng T, Homer RJ et al (2004b) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304:1678–1682
Zou L, He X, Zhang JW (2010) The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer. Braz J Med Biol Res 43:1232–1238
Z-u H, Dalal P, Aronson NN Jr, Madura JD (2007) Family 18 Chitolectins: Comparison of MGP40 and HUMGP39. Biochem Biophys Res Commun 359:221–226
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Wien
About this chapter
Cite this chapter
Gupta, R.K., Gupta, G.S. (2012). Chi-Lectins: Forms, Functions and Clinical Applications. In: Animal Lectins: Form, Function and Clinical Applications. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1065-2_19
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1065-2_19
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1064-5
Online ISBN: 978-3-7091-1065-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)